Factors affecting outcome in reverse transcriptase-polymerase chain reaction-positive lassa fever patients with acute kidney injury: A retrospective analysis

Abstract: Lassa fever (LF) is a viral haemorrhagic fever (VHF) endemic in the West African sub-region. It causes regular outbreaks with a significant case fatality rate (CFR). An estimated 100,000–300,000 people are infected with Lassa fever virus (LASV) every year in West Africa. Acute kidney injury (AKI) is a recognized complication of LF and may contribute significantly to the high CFR. We retrospectively studied 187 reverse transcriptase-polymerase chain reaction (RT-PCR)-positive LF patients admitted and managed at the infectious diseases centre of Abubakar Tafawa Balewa University Teaching (ATBUTH), Bauchi, to shed more light on the effect of AKI on the outcome. Materials and Methods: The case files of 187 RT-PCR-positive LF patients admitted between January 2018 and December 2020 at the infectious disease centre of ATBUTH were retrieved. We performed parametric and nonparametric statistical analyses including logistic regression to determine factors associated with poor outcomes. Results: During the study period, 187 RT-PCR-positive LF patients were admitted and treated in our centre; 130 (69.5%) were males and 27 (30.5%) were females. The mean age of presentation was 37.3 ± 15.5 years, and nearly all the patients presented with fevers of varying duration. There were 53 deaths with a CFR of 28.3%. More than 2/3 of the deaths were among the age group of 18–47 years. AKI was observed in 12.8% of the patients whose mean age was 37.17 ± 13.13 years. AKI was significantly associated with poor outcomes. Raised systolic blood pressure (odds ratio [OR] = 1.042, 95% confidence interval [CI] 1.008–1.076, P = 0.014) and serum creatinine (OR = 0.952, 95% CI 0.904–1.002, P = 0.000) were found as significant risk factors for developing AKI. Conclusion: Lassa fever is a multisystemic illness. Kidney involvement occur early and can lead to acute kidney injury with its attendant complications. Our study highlighted the significance of AKI as a contributor to poor outcome among patients with Lassa Fever infection.

[1]  Nehemias Guevara,et al.  The Risk of Severe Acute Kidney Injury Requiring Renal Replacement Therapy in Viral Hemorrhagic Fevers. A Review of Literature , 2022, International Journal of Clinical Medicine.

[2]  A. Flahault,et al.  Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design , 2021, PLoS neglected tropical diseases.

[3]  C. Picard,et al.  Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus , 2020, Emerging microbes & infections.

[4]  P. Rollin,et al.  Lassa Fever in Travelers from West Africa, 1969–2016 , 2019, Emerging infectious diseases.

[5]  P. Okokhere,et al.  Lassa fever outbreaks in Nigeria , 2018, Expert review of anti-infective therapy.

[6]  Pardis C Sabeti,et al.  Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study. , 2018, The Lancet. Infectious diseases.

[7]  A. Khan,et al.  Incidence, Characteristics and Risk Factors of Acute Kidney Injury among Dengue Patients: A Retrospective Analysis , 2015, PloS one.

[8]  Pardis C Sabeti,et al.  Lassa Fever in Post-Conflict Sierra Leone , 2014, PLoS neglected tropical diseases.

[9]  Jackson Tan,et al.  Acute kidney injury in dengue virus infection , 2012, Clinical kidney journal.

[10]  Amish D. Patel,et al.  Acute kidney injury in dengue fever using Acute Kidney Injury Network criteria: incidence and risk factors , 2012, Tropical doctor.

[11]  Norbert Lameire,et al.  Notice , 2012, Kidney International Supplements.

[12]  O. Ogbu,et al.  Lassa fever in West African sub-region: an overview. , 2007, Journal of vector borne diseases.

[13]  S. Günther,et al.  Mastomys natalensis and Lassa Fever, West Africa , 2006, Emerging infectious diseases.

[14]  S. Günther,et al.  Imported Lassa fever in Germany: surveillance and management of contact persons. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  J. Frame Clinical features of Lassa fever in Liberia. , 1989, Reviews of infectious diseases.

[16]  J. McCormick,et al.  A case-control study of the clinical diagnosis and course of Lassa fever. , 1987, The Journal of infectious diseases.

[17]  J. Frame,et al.  Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. , 1970, The American journal of tropical medicine and hygiene.